Institutional Ownership Denali Therapeutics Inc. (DNLI)
This table provides information about the institutional ownership of Denali Therapeutics Inc. (DNLI). We have compiled data on the 227 institutions that hold shares in the stock, with a total of 119 Million shares, which have been reported (via 13F filing form) to have a value of $2.54 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
13,345,887
shares
|
$287 Million
0.3% of portfolio
|
Q3 2024
Reduced 3.03%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,174,562
shares
|
$283 Million
0.01% of portfolio
|
Q2 2024
Added 7.99%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
11,177,234
shares
|
$240 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.2%
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
10,727,450
shares
|
$231 Million
0.06% of portfolio
|
Q3 2024
Added 9.2%
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
7,909,114
shares
|
$170 Million
0.05% of portfolio
|
Q3 2024
Added 10.98%
|
|
Temasek Holdings (Private) LTD
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
5,355,832
shares
|
$115 Million
0.64% of portfolio
|
Q3 2024
New holding
|
|
Crestline Management, LP
Fort Worth, TX |
Nov 13, 2024 Q3 2024 |
4,460,732
shares
|
$95.9 Million
6.91% of portfolio
|
Q3 2024
Reduced 6.3%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,252,011
shares
|
$91.4 Million
0.01% of portfolio
|
Q3 2024
Reduced 4.12%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
3,749,486
shares
|
$80.6 Million
0.03% of portfolio
|
Q3 2024
Added 63.18%
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
3,731,695
shares
|
$80.2 Million
1.16% of portfolio
|
Q1 2024
Added 43.13%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
3,047,264
shares
|
$65.5 Million
0.03% of portfolio
|
Q3 2024
Added 50.96%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,955,477
shares
|
$63.5 Million
0.01% of portfolio
|
Q3 2024
Reduced 0.91%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,869,795
shares
|
$61.7 Million
0.01% of portfolio
|
Q3 2024
Added 27.24%
|
|
Camber Capital Management LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,000,000
shares
|
$43 Million
1.85% of portfolio
|
Q2 2024
Added 33.33%
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
1,967,141
shares
|
$42.3 Million
0.07% of portfolio
|
Q3 2024
Reduced 18.67%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,744,755
shares
|
$37.5 Million
0.0% of portfolio
|
Q3 2024
Added 42.56%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,566,246
shares
|
$33.7 Million
0.03% of portfolio
|
Q1 2024
Reduced 0.63%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
1,559,442
shares
|
$33.5 Million
0.01% of portfolio
|
Q3 2024
Added 10.02%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
1,367,821
shares
|
$29.4 Million
0.01% of portfolio
|
Q3 2024
Added 12.22%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2024 Q3 2024 |
1,091,018
shares
|
$23.4 Million
0.05% of portfolio
|
Q3 2024
Reduced 4.42%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,085,642
shares
|
$23.3 Million
0.01% of portfolio
|
Q3 2024
Added 0.25%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,027,977
shares
|
$22.1 Million
0.04% of portfolio
|
Q2 2023
Reduced 17.66%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,015,810
shares
|
$21.8 Million
0.01% of portfolio
|
Q3 2024
Reduced 4.11%
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
990,000
shares
|
$21.3 Million
2.24% of portfolio
|
Q3 2024
Reduced 23.85%
|
|
Candriam S.C.A.
|
Nov 13, 2024 Q3 2024 |
942,158
shares
|
$20.2 Million
0.16% of portfolio
|
Q3 2024
Added 29.68%
|